SkyView Investment Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-48
Closed -$4K 205
2023
Q3
$4K Sell
48
-1
-2% -$90 ﹤0.01% 404
2023
Q2
$5K Sell
49
-3,442
-99% -$291K ﹤0.01% 490
2023
Q1
$264K Buy
3,491
+68
+2% +$5.13K 0.06% 322
2022
Q4
$263K Sell
3,423
-132
-4% -$10K 0.08% 293
2022
Q3
$237K Buy
3,555
+404
+13% +$25.6K 0.07% 350
2022
Q2
$164K Sell
3,151
-5,674
-64% -$322K 0.04% 409
2022
Q1
$500K Buy
8,825
+5,066
+135% +$271K 0.12% 250
2021
Q4
$444K Sell
3,759
-4,542
-55% -$223K 0.1% 243
2021
Q3
$411K Buy
8,301
+7,988
+2,552% +$433K 0.12% 207
2021
Q2
$19K Hold
313
0.01% 242
2021
Q1
$19K Buy
313
+258
+469% +$14.2K 0.01% 250
2020
Q4
$3K Buy
+55
New +$2.85K ﹤0.01% 259

Other funds holding CAH

SkyView Investment Advisors's CAH Position: Q4 2023 in Review

SkyView Investment Advisors sold out of Cardinal Health (CAH) in Q4 2023, closing a stake of 48 shares — an estimated $4K sold.

SkyView Investment Advisors first reported a position in CAH in Q4 2020 and held it in 12 quarters. The position peaked at $500K in Q1 2022. 1,037 funds tracked by Wall St. Rank hold CAH as of Q4 2023.

  • SkyView Investment Advisors reported no remaining Cardinal Health position as of Q4 2023 after selling out during the quarter.
  • SkyView Investment Advisors sold 48 Cardinal Health shares in Q4 2023, an estimated $4K.
  • SkyView Investment Advisors first reported a position in Cardinal Health in Q4 2020 and held it in 12 quarters.
  • SkyView Investment Advisors's Cardinal Health position peaked at $500K in Q1 2022.
  • 1,037 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2023.

Based on SkyView Investment Advisors's 13F filing for Q4 2023, filed 15 Feb 2024.